Brickell spends on drug trials, shares down 5%
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) reported a quarterly loss of $11.1 million Thursday after the closing bell; shares […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
Brickell Biotech launches brand reset amid positioning pivot
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company, has launched a new brand, logo and website as…
New hangar report encourages displaced aircraft owners
LOVELAND – The findings of a new and more positive structural study of two previously condemned general-aviation hangar buildings at…
NC apartment investor buys Touchstone Apartments for $117.5M
BROOMFIELD — Bell Partners Inc., a North Carolina-based multi-family housing investor and management company, bought the Touchstone Apartments community in…